Brief: Humacyte Q4 Basic EPS USD -0.24
22/03/2024 11:00
Mar 22 (Reuters) - Humacyte Q4 operating expenses USD 26.182 million. * Q4 operating income USD -26.182 million * Q4 net income USD -25.106 million
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary